- Academic Editor
†These authors contributed equally.
Background:The
atherogenic index of plasma (AIP), determined by the logarithmic transformation
of the ratio of triglyceride (TG) and high-density lipoprotein cholesterol
(HDL-C), was found to be a marker of cardiovascular disease. We sought to
investigate the correlation between the atherogenic AIP and coronary collateral circulation (CCC) formation in
chronic total occlusive (CTOs) patients. Methods: This
retrospective cohort study included 665 non-CTOs and 345 CTOs patients. CTOs were
divided into 206 CCC poor formation patients and 139 CCC good formation patients
according to the Cohen-Rentrop grade. Spearman correlation analysis was carried
out to obtain the relationship between AIP and the Rentrop grade. We used
multivariate logistic regression analysis to assess CTOs and CCC poor formation
risk factors. Receiver operating characteristic (ROC) curves were used to
determine the optimal threshold for AIP to predict CTOs and CCC poor formation.
The predicted increment of AIP on CTOs and CCC poor formation was evaluated by
calculating the Net Reclassification Index (NRI) and the Integrated Discriminant
Index (IDI). Results: AIP in CTOs was significantly elevated compared to
non-CTOs patients [(1.55 (1.02, 2.59)) vs (1.26 (0.82, 1.90)),
p
Chronic total occlusions (CTOs) are a common finding in patients with coronary artery disease (CAD), with a reported prevalence of approximately one-third in this patient population. This is a major global health concern in the field of cardiovascular medicine [1]. CTOs are frequently seen during coronary angiography and involve coronary artery complete occlusion for more than 3 months. Studies have indicated that the presence of CTOs is associated with a higher incidence of major adverse cardiovascular events (MACEs). This highlights the importance of identifying and treating CTOs in patients with CAD to reduce the risk of adverse cardiovascular outcomes [2]. Coronary collateral circulation (CCC) is an arterial anastomosis network that forms a natural bypass through arteriogenesis or lumen expansion when there is insufficient blood flow in the distal myocardium when coronary artery occlusion occurs [3]. A reduction in mortality and an improvement in cardiac function is associated with the presence of well-formed collaterals, which has cardioprotective effects on ischemic myocardium [4, 5]. Therefore, it is necessary to predict and evaluate the formation of CCC in clinical practice. However, the current methods to evaluate CCC such as the Collateral Flow Index (CFI) and intracoronary electrocardiogram are relatively complex and expensive. Therefore, there is a need for a simple and cost-effective method to effectively predict or evaluate the formation of CCC in CTO patients.
The atherogenic index of plasma (AIP), determined by the logarithmic transformation of the ratio of triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C), has been identified as a potential marker of cardiovascular disease. Studies have shown that AIP is associated with both the onset of CAD and the severity of coronary syndromes [6]. According to a recent study, there is a correlation between AIP levels and the severity of CTO. This suggests that AIP may be a useful biomarker for predicting the occurrence of CTO in patients with CAD [2]. Previous research has suggested that AIP levels may be an independent predictor of the complexity of CTO. This highlights the potential value of AIP as a biomarker for predicting not only the occurrence of CTO, but also their severity and complexity. In addition to the Japanese Multicenter CTO Registry (J-CTO) score, AIP may be associated with the number and length of stents used after successful revascularization [7]. However, the relationship between AIP and CTO and CCC formation has not been well studied. Therefore, we investigated the relationship between AIP and CTO as well as CCC formation to determine the effectiveness of AIP in the prediction and prognostic assessment of CTO patients in clinical practice.
Between January 2013 and September 2018, patients who underwent coronary angiography in the Department of Cardiology, Zhongnan Hospital of Wuhan University in whom the coronary angiography showed a 90% stenosis in at least one branch of the three main coronary arteries left anterior descending artery (LAD), left circumflex artery (LCA), and right coronary artery (RCA)) were consecutively enrolled [8]. CTO was defined as complete coronary artery occlusion due to thrombosis or atherosclerosis, with a duration of occlusion that lasted more than three months.
Exclusion criteria: Previous cardiovascular disease within three months (acute myocardial infarction, coronary stent placement or coronary artery bypass graft, heart failure), cardiomyopathy, congenital coronary arterial malformation or other severe diseases (liver and kidney failure, thyroid dysfunction) and patients taking lipid-lowering drugs for more than three months.
We followed the 2007 STROBE statement for reporting of observational studies [9].
Coronary angiography was performed by two interventional experts using the Judkin method by the radial or femoral approach. The Cohen-Rentrop criterion was used to evaluate CCC formation [10]: Grade 0, without any filling of the collateral arteries; Grade 1, the side branches of the occluded artery can be filled but the contrast agent cannot reach the epicardial vessel; Grade 2, partial filling of epicardial vessels; and Grade 3, epicardial vessels are completely filled. Based on the angiography results, the participants were divided into a CTOs group and a non-CTOs group. In addition, patients with CTO were separated into the CCC poor formation group (Rentrop Grade 0–1) and the CCC good formation group (Rentrop Grade 2–3).
Venous blood was obtained from patients who had fasted for more than 10 hours. Blood lipids were measured using an automated biochemical analyzer (Beckman Coulter, AU5800, Brea, CA, USA) and an enzymatic reaction method. TG/HDL was calculated as the ratio of serum TG (mmol/L) to serum HDL-C (mmol/L), and AIP was defined as the logarithm of the ratio of TG/HDL-C.
The Kolmogorov–Smirnov test was used to test the normality of data
distribution. Continuous data are shown as the mean
A total of 1412 patients who underwent coronary angiography in the Department of Cardiology, Zhongnan Hospital of Wuhan University were consecutively enrolled (Fig. 1). 402 patients who met the exclusion criteria were excluded. In total, 1010 patients were enrolled in the study, of whom 665 were non-CTO patients and 345 were CTO patients. Among the CTO patients, 139 patients were assigned to the good CCC formation group and 206 patients were assigned to the poor CCC formation group. Table 1 shows that 665 non-CTOs patients and 345 CTOs patients were included in this study. Patients in the CTOs group were older, more likely to be male and to have a history of smoking, diabetes, and hypertension, and a higher Lp(a) and AIP, but lower HDL levels.
Flowchart of the cohort patients. LAD, left anterior descending
artery; LCA, left circumflex artery; RCA, right coronary artery; AMI, acute
myocardial infarction; CABG, coronary artery bypass graft; HF, heart failure;
CTO, chronic total occlusive; CCC, coronary collateral circulation.
Variables | non-CTOs group (n = 665) | CTOs group (n = 345) | p value |
Age | 58.51 |
62.20 |
|
Gender (men (%)) | 353 (55.2) | 286 (82.9) | |
Smoking | 138 (20.8) | 165 (47.8) | |
Diabetes | 80 (12.0) | 99 (28.7) | |
Hypertension | 295 (58.2) | 212 (61.4) | |
TC (mmol/L) | 4.46 |
4.87 |
0.838 |
TG (mmoL/L) | 1.45 (1.01, 2.07) | 1.51 (1.06, 2.24) | 0.081 |
HDL (mmol/L) | 1.81 |
1.01 |
|
LDL (mmol/L) | 2.68 |
2.79 |
0.052 |
LP(a) (mg/L) | 109.95 (53.53, 210.63) | 127.70 (65.40, 243.65) | 0.011 |
AIP | 1.26 (0.82, 1.90) | 1.55 (1.02, 2.59) |
CTOs, chronic total occlusions; TC, total cholesterol; TG, triglyceride;
HDL, high-density lipoprotein; LDL, low-density lipoprotein; LP(a),
Lipoprotein(a); AIP, atherogenic index of plasma.
Note:
According to the Cohen-Rentrop criteria and the results of the CCC formation
evaluation, CTOs patients were divided into good and poor CCC groups, and AIP was
compared between these two groups. Table 2 showed that the CCC poor formation
group had a higher AIP ((0.14
Variables | Good CCC formation group (n = 139) | Poor CCC formation group (n = 206) | p value | |
Age | 63.30 |
61.46 |
||
Gender [man (%)] | 120 (42.0) | 166 (58.0) | 0.190 | |
Smoking | 68 (41.2) | 97 (58.8) | 0.743 | |
Diabetes | 38 (38.4) | 61 (61.6) | 0.716 | |
Hypertension | 92 (43.4) | 120 (56.6) | 0.144 | |
TC (mmol/L) | 4.31 |
4.59 |
0.010 | |
TG (mmoL/L) | 1.45 (1.01, 2.07) | 1.51 (1.06, 2.24) | 0.081 | |
HDL (mmol/L) | 1.06 |
0.98 |
0.010 | |
LDL (mmol/L) | 2.69 |
2.86 |
0.048 | |
LP(a) (mg/L) | 109.95 (53.53, 210.63) | 127.70 (65.40, 243.65) | 0.011 | |
AIP | 1.37 (0.84, 2.13) | 1.73 (1.12, 2.90) | 0.002 | |
Occlusive vessel (%) | ||||
Multiple vessels lesions | 31 (63.3) | 18 (36.7) | 0.001 | |
LAD | 37 (37.4) | 62 (62.6) | 0.544 | |
LCX | 19 (27.1) | 51 (72.9) | 0.014 | |
RCA | 52 (40.9) | 75 (59.1) | 0.909 |
CTOs, chronic total occlusions; CCC, coronary collateral circulation; TC, total cholesterol; TG, triglyceride;
HDL, high-density lipoprotein; LDL, low-density lipoprotein; LP(a),
Lipoprotein(a); LAD, left anterior descending artery; AIP, atherogenic index of
plasma; RCA, right coronary artery; LCX, left circumflex artery.
Note:
Spearman’s correlation analysis was carried out to obtain the relationship between AIP and the Rentrop grade. The results showed that AIP (r = –0.145, p = 0.007) was negatively correlated with Rentrop grade. The AIP in Rentrop 3 (1.22 (0.8, 1.94)) and Rentrop 2 (1.53 (0.89, 2.36)) were significantly lower than Rentrop 0 (1.65 (1.12, 2.9)) and Rentrop 1 (1.97 (1.14, 2.85)). The AIP between Rentrop 3 and Rentrop 2 (p = 0.269), Rentrop 0 and Rentrop 1 (p = 0.351) showed no significant differences.
The CTOs (yes or no) and CCC formation (good
or poor) were used as the dependent variables. Variables with a univariate
relationship with outcome and clinical relevance were included in multivariate
models to reveal potential risk factors for CTO and CCC. Since the tolerance of
TG and HDL-C were both
Variables | B | Wald | OR | 95% CI | p value |
Age | 0.052 | 44.151 | 1.053 | 1.037–1.069 | |
Sex | –1.374 | 46.014 | 0.253 | 0.170–1.069 | |
Smoking | 0.849 | 22.374 | 2.337 | 1.644–3.323 | |
Diabetes | 0.875 | 19.100 | 2.399 | 1.620–3.551 | |
Hypertension | 0.481 | 8.990 | 1.618 | 1.181–2.217 | 0.003 |
TC (mmol/L) | –0.369 | 5.547 | 0.692 | 0.509–0.940 | 0.019 |
LDL (mmol/L) | 0.557 | 8.627 | 1.746 | 1.204–2.532 | 0.003 |
Lp(a) (mg/L) | 0.001 | 7.420 | 1.001 | 1.000–1.002 | 0.006 |
AIP | 1.475 | 24.455 | 4.371 | 2.436–7.844 |
OR, odds ratio; CI, confidence interval; TC, total cholesterol; CTOs, chronic total occlusions; LDL, low-density lipoprotein; LP(a), Lipoprotein(a); AIP, atherogenic index of plasma.
Variables | B | Wald | OR | 95% CI | p value |
Age | 0.000 | 0.001 | 1.000 | 0.978–1.023 | 0.970 |
Sex | 0.461 | 1.764 | 1.585 | 0.803–3.130 | 0.184 |
Smoking | –0.074 | 0.082 | 0.928 | 0.559–1.543 | 0.775 |
Diabetes | 0.032 | 0.015 | 1.033 | 0.615–1.734 | 0.903 |
Hypertension | –0.411 | 2.767 | 0.663 | 0.408–1.076 | 0.096 |
Multivessel | –1.183 | 12.519 | 0.306 | 0.159–0.590 | 0.001 |
TC (mmol/L) | –0.005 | 0.000 | 0.995 | 0.621–1.595 | 0.984 |
LDL (mmol/L) | 0.330 | 1.134 | 1.391 | 0.758–2.556 | 0.287 |
Lp(a) (mg/L) | –0.001 | 2.610 | 0.999 | 0.998–1.000 | 0.106 |
AIP | 1.303 | 7.978 | 3.680 | 1.490–9.090 | 0.005 |
OR, odds ratio; CI, confidence interval; TC, total cholesterol; LDL, low-density lipoprotein; LP(a), Lipoprotein(a); CCC, coronary collateral circulation; AIP, atherogenic index of plasma.
After ROC analysis, the area under the curve
of CTOs and CCCs detected by AIP was 0.596 (95% CI: 0.559–0.633, p
AIP prediction of CTOs with ROC curves. AIP, atherogenic index of plasma; CTOs, chronic total occlusions; ROC, receiver operating characteristic.
AIP prediction of CCC poor formation with ROC curves. CCC, coronary collateral circulation; ROC, receiver operating characteristic.
We calculated the net reclassification index (NRI) and integrated discrimination index (IDI) to evaluate the predicted increment of AIP on CTOs and CCC poor formation. We constructed a standard model using the risk factors in the above analysis that may be associated with CTOs and CCC poor formation (i.e., age, gender, smoking, diabetes, hypertension for CTOs, and for CCC poor formation, multivessel coronary disease is added). Adding AIP to the standard model forms a new model. Based on previous research [11, 12, 13, 14, 15, 16, 17, 18, 19], we set the cut-off point for CTOs as 0.2, 0.4, 0.8 and the cut-off point for CCC poor formation was 0.25 and 0.5. The final results suggest that the NRI for predicting CTO lesions and poor CCC formation are 0.066 (95% CI: –0.002 to 0.122, p = 0.044) and 0.016 (95% CI: –0.039 to 0.183, p = 0.761), respectively. The NRI of CTO patients and non-CTO patients were 0.032 (95% CI: –0.018 to 0.054, p = 0.083) and 0.034 (95% CI: –0.006 to 0.093, p = 0.169), respectively. The NRI of poor and well-formed CCC groups were –0.005 (95% CI: –0.091 to 0.020, p = 0.866) and 0.022 (95% CI: –0.017 to 0.224, p = 0.740), respectively. The NRI matrix of AIP predicting CTO lesions and poor CCC formation is shown in Figs. 4,5, respectively.
NRI matrix of AIP predicting CTO lesions. NRI, net reclassification index; AIP, atherogenic index of plasma; CTO, chronic total occlusive; CCC, coronary collateral circulation.
NRI matrix of AIP predicting CCC poor formation. NRI, net reclassification index; AIP, atherogenic index of plasma; CCC, coronary collateral circulation; CTO, chronic total occlusion.
The present study demonstrated that (1) AIP was significantly higher in the CTOs group compared with the non-CTOs group, (2) AIP of CTOs patients with the poor CCC formation group was significantly higher than that of the good CCC formation group, (3) the AIP was positively associated with a higher prevalence of CTOs and CCC poor formation and (4) AIP is a moderate predictor of CTO and poor CCC formation. According to the above results, AIP may provide some assistance in the diagnosis, prognosis, and risk assessment of CTO patients. AIP may also provide some value for judging the poor formation of CCC in CTO patients. The area under the ROC of AIP detection of CTO patients and poor CCC formation is less than 0.7, which means that AIP is only a moderate indicator of CTO and poor CCC formation. This differs from previous findings, possibly due to the characteristics of observational studies and the relatively small sample size of this study.
CTO is one of the leading causes of death in CAD patients because of its complexity and operating procedure difficulty. A well-developed CCC could have a favorable impact on outcomes and functions for CTOs patients. Studies have shown that CCC formation could play an important role in reducing mortality, recurrence of myocardial infarction, MACE and improving the overall prognosis of patients [20, 21, 22]. While CCC formation is involved in disorders of metabolism, evidence has shown that CCC formation is associated with diabetes, metabolic syndrome, and dyslipidemia. The underlying factors contributing to this association may involve endothelial and smooth muscle cell dysfunction, as well as inflammatory cells and cytokines caused by the hostile metabolic environment [3, 23].
Dyslipidemia is traditionally a contributing factor to CAD. Current studies revealed that elevated plasma levels of TG and low plasma concentrations of HDL-C are closely associated with a high risk of CAD, even at or below recommended LDL-C goals [24, 25]. Experimental evidence showed that TG and HDL-C play a role in the pathophysiology of atherothrombosis. TG may provoke atherogenesis by upregulating the production of pro-inflammatory cytokines and enhancing inflammatory response and cell activation [26, 27]. In addition, the elevation of TG could stimulate the secretion of tissue factors from endothelial cells and monocytes, and are related to an increase of fibrinogen and coagulation factors in the plasma [28, 29]. A study suggested that TG could directly contribute to plaque formation and progression [30]. The functionality of HDL is relevant to atheroprotective effects, including anti-inflammatory and anti-thrombotic activities, anti-apoptosis of endothelial cells, and anti-oxidative stress in the process of atherosclerosis [31]. HDL facilitates cholesterol efflux from lipid-rich macrophages within atherosclerotic plaques in the arterial walls. This efflux is mediated by the interactions of apolipoprotein A-I (apoA-I) with adenosine triphosphate-binding cassette transporter A1 (ABCA1). The cholesterol is then transported to the liver for metabolism or biliary excretion [32]. Furthermore, HDL has anti-inflammatory and anti-oxidative effects by regulating endothelial homeostasis and anti-thrombus through attenuation of platelet aggregation and adhesion responses [33]. Thus, it seems more reasonable to use AIP to predict CTOs and CCC formation, since this index represents the ratio of atherosclerosis particles to anti-atherosclerosis particles in the plasma. These protective mechanisms could be related to endothelial function and inflammation in the atherosclerosis process.
The AIP is determined by the logarithmic transformation of the ratio of
triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C). Many studies
have focused on the relationship between AIP and CAD risk. Previous research
links AIP to obesity, hypertension, diabetes, and metabolic syndrome [34]. A
study also found that AIP was significantly higher in CAD patients compared with
healthy individuals [35], and that AIP was associated with the severity of acute
coronary syndrome in young adults [36]. In another study [6], AIP was an independent
risk factor for CAD and a higher SYNTAX score
Our study has several limitations. First, all the data in this study were collected from a single hospital and analyzed retrospectively. Therefore, the data could be influenced by measurements, operators, and techniques, and selection bias could exist. Second, we used coronary angiography to evaluate CCC and Rentrop grade, the accuracy of which is far lower than other methods (e.g., CFI). The catheter size and the spatial resolution of the angiography system could have affected the results of the Rentrop grade in this study. Finally, the present study did not completely demonstrate the underlying mechanism between AIP and CCC formation in CTOs patients.
AIP was significantly higher in the CTOs group and the poor CCC formation group compared with the non-CTOs group and good CCC formation group. We found that AIP was positively correlated with the increased risk of CTOs and poor CCC formation. We found AIP to be a moderate but not powerful indicator for detecting both CTO patients and poor CCC formation. AIP may be used as a noninvasive biomarker to evaluate CTOs and poor CCC formation in clinical practice.
AIP, atherogenic index of plasma; CAD, coronary artery disease; CTOs, Chronic total occlusions; CCC, coronary collateral circulation; ROC, Receiver operating characteristic; LDL-C, low-density lipoprotein cholesterol; non-HDL-C, nonhigh-density lipoprotein cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LP(a), Lipoprotein(a); CI, confidence interval; LAD, left anterior descending artery; LCA, left circumflex artery; RCA, right coronary artery; CFI, Collateral Flow Index; MACE, major adverse cardiovascular events; PCI, percutaneous coronary intervention; J-CTO score, Japanese Multicenter CTO Registry score; TIMI, Thrombolysis in Myocardial Infarction.
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
YL, YF, and YZ designed the research and drafted the manuscript. YL, YF, SL, JL and PF collected the data and helped implement and analyze the research. YZ, MZ and JW interpreted the data and reviewed the results, revised the manuscript, and confirmed the final published version. All of the authors read and approved the final manuscript. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.
The study protocol was approved by the Ethics Committee of the Zhongnan Hospital of Wuhan University (ethics number: 2023079K) and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Written informed consent was also waived because of the retrospective and observational nature of the study. We have de-identified all patient details to ensure they cannot be identified.
Thanks to all the members of the research group and friends who have helped us in this process.
This study was supported by the Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University (grant number ZNJC202201).
The authors declare no conflict of interest.
Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.